Pentasa (Ulcerative Colitis) Market Report

Japan Pentasa (Ulcerative Colitis) Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 15, 2019
  • PAGES：211
  • REPORT CODE：GMM239295
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Pentasa (Ulcerative Colitis) market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Pentasa (Ulcerative Colitis) market. Detailed analysis of key players, along with key growth strategies adopted by Pentasa (Ulcerative Colitis) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Treato

    • Ferring GmbH

    • Shire US Inc

    • Laboratórios Ferring Ltda

    • Prasco

    • Takeda's Entyvio.

    • Prescription Hope, Inc

    • GiCare


    By Type:

    • Pentasa tablets

    • Pentasa granules


    By End-User:

    • Ulcerative colitis

    • Crohn's disease


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pentasa (Ulcerative Colitis) Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Pentasa (Ulcerative Colitis) Market Size and Growth Rate of Pentasa tablets from 2014 to 2026

      • 1.3.2 Japan Pentasa (Ulcerative Colitis) Market Size and Growth Rate of Pentasa granules from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Pentasa (Ulcerative Colitis) Market Size and Growth Rate of Ulcerative colitis from 2014 to 2026

      • 1.4.2 Japan Pentasa (Ulcerative Colitis) Market Size and Growth Rate of Crohn's disease from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Pentasa (Ulcerative Colitis) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pentasa (Ulcerative Colitis) by Major Types

      • 3.4.1 Market Size and Growth Rate of Pentasa tablets

      • 3.4.2 Market Size and Growth Rate of Pentasa granules

    4 Segmentation of Pentasa (Ulcerative Colitis) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pentasa (Ulcerative Colitis) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pentasa (Ulcerative Colitis) in Ulcerative colitis

      • 4.4.2 Market Size and Growth Rate of Pentasa (Ulcerative Colitis) in Crohn's disease


    5 Market Analysis by Regions

    • 5.1 Japan Pentasa (Ulcerative Colitis) Production Analysis by Regions

    • 5.2 Japan Pentasa (Ulcerative Colitis) Consumption Analysis by Regions


    6 Hokkaido Pentasa (Ulcerative Colitis) Landscape Analysis

    • 6.1 Hokkaido Pentasa (Ulcerative Colitis) Landscape Analysis by Major Types

    • 6.2 Hokkaido Pentasa (Ulcerative Colitis) Landscape Analysis by Major End-Users


    7 Tohoku Pentasa (Ulcerative Colitis) Landscape Analysis

    • 7.1 Tohoku Pentasa (Ulcerative Colitis) Landscape Analysis by Major Types

    • 7.2 Tohoku Pentasa (Ulcerative Colitis) Landscape Analysis by Major End-Users


    8 Kanto Pentasa (Ulcerative Colitis) Landscape Analysis

    • 8.1 Kanto Pentasa (Ulcerative Colitis) Landscape Analysis by Major Types

    • 8.2 Kanto Pentasa (Ulcerative Colitis) Landscape Analysis by Major End-Users


    9 Chubu Pentasa (Ulcerative Colitis) Landscape Analysis

    • 9.1 Chubu Pentasa (Ulcerative Colitis) Landscape Analysis by Major Types

    • 9.2 Chubu Pentasa (Ulcerative Colitis) Landscape Analysis by Major End-Users


    10 Kinki Pentasa (Ulcerative Colitis) Landscape Analysis

    • 10.1 Kinki Pentasa (Ulcerative Colitis) Landscape Analysis by Major Types

    • 10.2 Kinki Pentasa (Ulcerative Colitis) Landscape Analysis by Major End-Users


    11 Chugoku Pentasa (Ulcerative Colitis) Landscape Analysis

    • 11.1 Chugoku Pentasa (Ulcerative Colitis) Landscape Analysis by Major Types

    • 11.2 Chugoku Pentasa (Ulcerative Colitis) Landscape Analysis by Major End-Users


    12 Shikoku Pentasa (Ulcerative Colitis) Landscape Analysis

    • 12.1 Shikoku Pentasa (Ulcerative Colitis) Landscape Analysis by Major Types

    • 12.2 Shikoku Pentasa (Ulcerative Colitis) Landscape Analysis by Major End-Users


    13 Kyushu Pentasa (Ulcerative Colitis) Landscape Analysis

    • 13.1 Kyushu Pentasa (Ulcerative Colitis) Landscape Analysis by Major Types

    • 13.2 Kyushu Pentasa (Ulcerative Colitis) Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Treato

      • 14.1.1 Treato Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Ferring GmbH

      • 14.2.1 Ferring GmbH Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Shire US Inc

      • 14.3.1 Shire US Inc Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Laboratórios Ferring Ltda

      • 14.4.1 Laboratórios Ferring Ltda Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Prasco

      • 14.5.1 Prasco Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Takeda's Entyvio.

      • 14.6.1 Takeda's Entyvio. Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Prescription Hope, Inc

      • 14.7.1 Prescription Hope, Inc Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 GiCare

      • 14.8.1 GiCare Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 140 Figures and 124 Tables)

     

    • Figure Japan Pentasa (Ulcerative Colitis) Market Size and Growth Rate of Pentasa tablets from 2014 to 2026

    • Figure Japan Pentasa (Ulcerative Colitis) Market Size and Growth Rate of Pentasa granules from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Pentasa (Ulcerative Colitis) Market Size and Growth Rate of Ulcerative colitis from 2014 to 2026

    • Figure Japan Pentasa (Ulcerative Colitis) Market Size and Growth Rate of Crohn's disease from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Pentasa (Ulcerative Colitis) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Pentasa (Ulcerative Colitis) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Pentasa (Ulcerative Colitis)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pentasa (Ulcerative Colitis) by Different Types from 2014 to 2026

    • Table Consumption Share of Pentasa (Ulcerative Colitis) by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Pentasa tablets

    • Figure Market Size and Growth Rate of Pentasa granules

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Pentasa (Ulcerative Colitis) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Pentasa (Ulcerative Colitis) by Different End-Users from 2014 to 2026

    • Figure Japan Pentasa (Ulcerative Colitis) Market Size and Growth Rate of Ulcerative colitis from 2014 to 2026

    • Figure Japan Pentasa (Ulcerative Colitis) Market Size and Growth Rate of Crohn's disease from 2014 to 2026

    • Table Japan Pentasa (Ulcerative Colitis) Production by Regions

    • Table Japan Pentasa (Ulcerative Colitis) Production Share by Regions

    • Figure Japan Pentasa (Ulcerative Colitis) Production Share by Regions in 2014

    • Figure Japan Pentasa (Ulcerative Colitis) Production Share by Regions in 2018

    • Figure Japan Pentasa (Ulcerative Colitis) Production Share by Regions in 2026

    • Table Japan Pentasa (Ulcerative Colitis) Consumption by Regions

    • Table Japan Pentasa (Ulcerative Colitis) Consumption Share by Regions

    • Figure Japan Pentasa (Ulcerative Colitis) Consumption Share by Regions in 2014

    • Figure Japan Pentasa (Ulcerative Colitis) Consumption Share by Regions in 2018

    • Figure Japan Pentasa (Ulcerative Colitis) Consumption Share by Regions in 2026

    • Table Hokkaido Pentasa (Ulcerative Colitis) Consumption by Types from 2014 to 2026

    • Table Hokkaido Pentasa (Ulcerative Colitis) Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Pentasa (Ulcerative Colitis) Consumption Share by Types in 2014

    • Figure Hokkaido Pentasa (Ulcerative Colitis) Consumption Share by Types in 2018

    • Figure Hokkaido Pentasa (Ulcerative Colitis) Consumption Share by Types in 2026

    • Table Hokkaido Pentasa (Ulcerative Colitis) Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Pentasa (Ulcerative Colitis) Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2014

    • Figure Hokkaido Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2018

    • Figure Hokkaido Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2026

    • Table Tohoku Pentasa (Ulcerative Colitis) Consumption by Types from 2014 to 2026

    • Table Tohoku Pentasa (Ulcerative Colitis) Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Pentasa (Ulcerative Colitis) Consumption Share by Types in 2014

    • Figure Tohoku Pentasa (Ulcerative Colitis) Consumption Share by Types in 2018

    • Figure Tohoku Pentasa (Ulcerative Colitis) Consumption Share by Types in 2026

    • Table Tohoku Pentasa (Ulcerative Colitis) Consumption by End-Users from 2014 to 2026

    • Table Tohoku Pentasa (Ulcerative Colitis) Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2014

    • Figure Tohoku Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2018

    • Figure Tohoku Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2026

    • Table Kanto Pentasa (Ulcerative Colitis) Consumption by Types from 2014 to 2026

    • Table Kanto Pentasa (Ulcerative Colitis) Consumption Share by Types from 2014 to 2026

    • Figure Kanto Pentasa (Ulcerative Colitis) Consumption Share by Types in 2014

    • Figure Kanto Pentasa (Ulcerative Colitis) Consumption Share by Types in 2018

    • Figure Kanto Pentasa (Ulcerative Colitis) Consumption Share by Types in 2026

    • Table Kanto Pentasa (Ulcerative Colitis) Consumption by End-Users from 2014 to 2026

    • Table Kanto Pentasa (Ulcerative Colitis) Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2014

    • Figure Kanto Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2018

    • Figure Kanto Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2026

    • Table Chubu Pentasa (Ulcerative Colitis) Consumption by Types from 2014 to 2026

    • Table Chubu Pentasa (Ulcerative Colitis) Consumption Share by Types from 2014 to 2026

    • Figure Chubu Pentasa (Ulcerative Colitis) Consumption Share by Types in 2014

    • Figure Chubu Pentasa (Ulcerative Colitis) Consumption Share by Types in 2018

    • Figure Chubu Pentasa (Ulcerative Colitis) Consumption Share by Types in 2026

    • Table Chubu Pentasa (Ulcerative Colitis) Consumption by End-Users from 2014 to 2026

    • Table Chubu Pentasa (Ulcerative Colitis) Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2014

    • Figure Chubu Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2018

    • Figure Chubu Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2026

    • Table Kinki Pentasa (Ulcerative Colitis) Consumption by Types from 2014 to 2026

    • Table Kinki Pentasa (Ulcerative Colitis) Consumption Share by Types from 2014 to 2026

    • Figure Kinki Pentasa (Ulcerative Colitis) Consumption Share by Types in 2014

    • Figure Kinki Pentasa (Ulcerative Colitis) Consumption Share by Types in 2018

    • Figure Kinki Pentasa (Ulcerative Colitis) Consumption Share by Types in 2026

    • Table Kinki Pentasa (Ulcerative Colitis) Consumption by End-Users from 2014 to 2026

    • Table Kinki Pentasa (Ulcerative Colitis) Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2014

    • Figure Kinki Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2018

    • Figure Kinki Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2026

    • Table Chugoku Pentasa (Ulcerative Colitis) Consumption by Types from 2014 to 2026

    • Table Chugoku Pentasa (Ulcerative Colitis) Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Pentasa (Ulcerative Colitis) Consumption Share by Types in 2014

    • Figure Chugoku Pentasa (Ulcerative Colitis) Consumption Share by Types in 2018

    • Figure Chugoku Pentasa (Ulcerative Colitis) Consumption Share by Types in 2026

    • Table Chugoku Pentasa (Ulcerative Colitis) Consumption by End-Users from 2014 to 2026

    • Table Chugoku Pentasa (Ulcerative Colitis) Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2014

    • Figure Chugoku Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2018

    • Figure Chugoku Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2026

    • Table Shikoku Pentasa (Ulcerative Colitis) Consumption by Types from 2014 to 2026

    • Table Shikoku Pentasa (Ulcerative Colitis) Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Pentasa (Ulcerative Colitis) Consumption Share by Types in 2014

    • Figure Shikoku Pentasa (Ulcerative Colitis) Consumption Share by Types in 2018

    • Figure Shikoku Pentasa (Ulcerative Colitis) Consumption Share by Types in 2026

    • Table Shikoku Pentasa (Ulcerative Colitis) Consumption by End-Users from 2014 to 2026

    • Table Shikoku Pentasa (Ulcerative Colitis) Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2014

    • Figure Shikoku Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2018

    • Figure Shikoku Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2026

    • Table Kyushu Pentasa (Ulcerative Colitis) Consumption by Types from 2014 to 2026

    • Table Kyushu Pentasa (Ulcerative Colitis) Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Pentasa (Ulcerative Colitis) Consumption Share by Types in 2014

    • Figure Kyushu Pentasa (Ulcerative Colitis) Consumption Share by Types in 2018

    • Figure Kyushu Pentasa (Ulcerative Colitis) Consumption Share by Types in 2026

    • Table Kyushu Pentasa (Ulcerative Colitis) Consumption by End-Users from 2014 to 2026

    • Table Kyushu Pentasa (Ulcerative Colitis) Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2014

    • Figure Kyushu Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2018

    • Figure Kyushu Pentasa (Ulcerative Colitis) Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Treato

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Treato

    • Figure Sales and Growth Rate Analysis of Treato

    • Figure Revenue and Market Share Analysis of Treato

    • Table Product and Service Introduction of Treato

    • Table Company Profile and Development Status of Ferring GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring GmbH

    • Figure Sales and Growth Rate Analysis of Ferring GmbH

    • Figure Revenue and Market Share Analysis of Ferring GmbH

    • Table Product and Service Introduction of Ferring GmbH

    • Table Company Profile and Development Status of Shire US Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire US Inc

    • Figure Sales and Growth Rate Analysis of Shire US Inc

    • Figure Revenue and Market Share Analysis of Shire US Inc

    • Table Product and Service Introduction of Shire US Inc

    • Table Company Profile and Development Status of Laboratórios Ferring Ltda

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Laboratórios Ferring Ltda

    • Figure Sales and Growth Rate Analysis of Laboratórios Ferring Ltda

    • Figure Revenue and Market Share Analysis of Laboratórios Ferring Ltda

    • Table Product and Service Introduction of Laboratórios Ferring Ltda

    • Table Company Profile and Development Status of Prasco

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Prasco

    • Figure Sales and Growth Rate Analysis of Prasco

    • Figure Revenue and Market Share Analysis of Prasco

    • Table Product and Service Introduction of Prasco

    • Table Company Profile and Development Status of Takeda's Entyvio.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda's Entyvio.

    • Figure Sales and Growth Rate Analysis of Takeda's Entyvio.

    • Figure Revenue and Market Share Analysis of Takeda's Entyvio.

    • Table Product and Service Introduction of Takeda's Entyvio.

    • Table Company Profile and Development Status of Prescription Hope, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Prescription Hope, Inc

    • Figure Sales and Growth Rate Analysis of Prescription Hope, Inc

    • Figure Revenue and Market Share Analysis of Prescription Hope, Inc

    • Table Product and Service Introduction of Prescription Hope, Inc

    • Table Company Profile and Development Status of GiCare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GiCare

    • Figure Sales and Growth Rate Analysis of GiCare

    • Figure Revenue and Market Share Analysis of GiCare

    • Table Product and Service Introduction of GiCare

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US